Pfizer, BioNTech could supply EU with 300m doses of SARS-CoV-2 vaccine
The proposed deal covers the initial supply of 200 million doses and an option to purchase an additional 100 million, with deliveries starting by the end of 2020, if the vaccine is approved
Read More
